Poll: What Is the Best Way to Improve Biosimilar Access?

April 14, 2021

Opinions are diverse on how best to clear the obstructions to biosimilar market entry and patient access.

NORC: Pricing Transparency Could Aid Biosimilar Uptake
NORC: Doctors Must Overcome Patient Hesitation on Biosimilars
News Roundup: Bio-Thera, Henlius Advance Biologics Development
Green Shield Canada: Preferential Status Is Vital to Biosimilar Uptake